Weight Loss Drugs Effective but Confer ‘No Benefit’ to Quality of Life
The review found semaglutide and tirzepatide drove 10% to 15% average weight loss, but generic quality-of-life gains stayed below the authors' threshold.
10 Articles
10 Articles
"Subcutaneous semaglutide alone clearly reduces the risk of death and infarction," researchers said, who analyzed 262 studies on LPG-1 drugs.
Only one weight-loss jab shown to cut risk of death, landmark study finds
Oral versions of Wegovy perform as well as injectable forms for weight loss, though the tablets may not confer the same heart-protective effects, a major study published in the British Medical Journal has found.While analysing all available evidence on weight-loss medications, researchers found that despite helping patients lose weight, the majority of obesity treatments, including Wegovy and Mounjaro, fail to produce meaningful improvements in …
Doctor loses 40kg, says weight-loss drugs require lifelong use
A doctor who lost 40 kilograms using GLP-1 weight-loss drugs said patients must remain on the medication to maintain weight loss, citing studies that show patients regain weight if treatment stops. Dr. Jang Hyung-woo, a cardiothoracic surgeon and professor at Bundang Seoul National University Hospital, appeared on CBS Radio's "Park Sung-tae's News Show" on Tuesday to discuss his personal and medical experience with the medications. Jang said obe…
Coverage Details
Bias Distribution
- 43% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium









